Inactive Instrument
Quotes Oramed Pharmaceuticals, Inc. OTC Bulletin Board
Stocks
US68403P1049
Biotechnology & Medical Research
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 09-21 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Stock exchange
OTC Bulletin Board- $
-
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ORMP | 4.550USD | +1.34% | 474K $ | ||
CBOE
| ORMP | 4.540USD | +2.02% | 24.3K $ | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | 1,409.00ILa | -0.21% | 292K ILa | |
|
Tradegate
| OJU1 | 4.050EUR | +1.63% | 24.3 € | |
|
Deutsche Boerse AG
| OJU1 | 3.995EUR | -0.12% | 0 € | |
|
Börse Stuttgart
| OJU1 | 4.015EUR | +0.25% | 0 € | |
|
Boerse Muenchen
| OJU1 | 4.015EUR | 0.00% | 0 € |
Basic data
Market Cap (USD)
189,267,960
Net sales (USD)
2,000,000
Free-Float
78.61%
Free-Float capitalization (USD)
148,781,446
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 189M | |
| +4.16% | +3.42% | +49.37% | +94.17% | 74.31B | |
| +1.94% | -2.38% | +21.83% | +77.12% | 56.95B | |
| +2.77% | +0.92% | +5.78% | +37.39% | 48.3B | |
| +0.50% | +2.94% | +344.62% | +722.17% | 44.51B | |
| +3.05% | -1.80% | +28.78% | +34.51% | 43.8B | |
| +1.00% | -1.46% | +5.17% | +111.90% | 41.12B | |
| -0.54% | +2.41% | +9.31% | +58.85% | 31.07B | |
| +4.51% | +8.22% | +37.86% | +32.49% | 28.97B | |
| +0.76% | -1.45% | -7.44% | -11.12% | 24.53B | |
| Average | +2.01% | -0.15% | +55.03% | +128.61% | 39.38B | |
| Weighted average by Cap. | +2.24% | -0.46% | +58.97% | +137.09% |
Historical Quotes: Oramed Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- ORMP Stock
- Stock
- Quotes Oramed Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
